Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the ...

Key Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.

Tirzepatide and semaglutide confer greater weight loss than other FDA-approved obesity medications with no significantly higher risk for adverse events, according to findings from a network meta ...

IT seems every week there’s a new claim about what fat jabs can cure – beyond banishing that belly. The so-called skinny jabs – that were initially designed as treatment for type ...

Tirzepatide 15 mg emerged as superior to other GLP-1 agonists for weight loss, for example, in a network meta-analysis of randomized controlled trials looking into obesity management.

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.

Cardiology and GLP-1s: 10 things to know Advertisement. By: Francesca Mathewes. Thursday, June 26th, 2025. Print ... including the use of newly approved drugs, including GLP-1 receptor agonists like ...